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Human positive cofactor 4 (PC4) is a transcriptional coactivator with a highly conserved single-strand DNA
(ssDNA) binding domain of unknown function. We identified PC4 as a suppressor of the oxidative mutator
phenotype of the Escherichia coli fpg mutY mutant and demonstrate that this suppression requires its ssDNA
binding activity. Saccharomyces cerevisiae mutants lacking their PC4 ortholog Sub1 are sensitive to hydrogen
peroxide and exhibit spontaneous and peroxide-induced hypermutability. PC4 expression suppresses the
peroxide sensitivity of the yeast sub1mutant, suggesting that the human protein has a similar function. A role
for yeast and human proteins in DNA repair is suggested by the demonstration that Sub1 acts in a peroxide
resistance pathway involving Rad2 and by the physical interaction of PC4 with the human Rad2 homolog XPG.
We show that XPG recruits PC4 to a bubble-containing DNA substrate with a resulting displacement of XPG
and formation of a PC4-DNA complex. We discuss the possible requirement for PC4 in either global or
transcription-coupled repair of oxidative DNA damage to mediate the release of XPG bound to its substrate.
Oxidative DNA damage and the mutations it causes have
been implicated in a number of human diseases, including
cancer and neurodegenerative diseases, and are a contributing
factor to aging (6, 12, 35, 36). Thus, a thorough understanding
of genes involved in the prevention and repair of oxidative
DNA damage and its mutagenic consequences is important to
our understanding of the mechanisms mitigating these diseases
and exacerbating normal degenerative processes associated
with aging.
Oxidative DNA damage results from the interaction of re-
active oxygen species (ROS) with DNA. ROS are produced as
by-products of normal aerobic metabolism and by exogenous
factors, such as ionizing radiation and chemical oxidants (6, 12,
35, 36). The deleterious consequences of ROS to an organism’s
genetic material are held in check by proteins that prevent or
repair oxidative DNA damage (7, 12, 13, 15, 21). Unrepaired
oxidative lesions result in increased mutagenesis, lethality, and
apoptosis (23, 27). A balance between DNA repair and dam-
age prevention mechanisms and ROS production is required to
maintain a low spontaneous mutation rate. Factors that in-
crease ROS production, reduce ROS detoxification, or factors
that affect repair of oxidative DNA lesions result in increased
mutagenesis. This is best demonstrated in Escherichia coli;
mutations that inactivate the fpg and mutY genes, whose prod-
ucts repair the predominant oxidative lesion 8-oxoguanine (8-
oxoG) and its mispaired intermediate 8-oxoG:A, respectively,
result in a mutator phenotype that specifically increases GC3
TA transversion mutagenesis (37).
In this study, we screened a human cDNA library and de-
scribe the isolation and characterization of the human tran-
scription positive cofactor 4 (PC4) gene as a suppressor of
oxidative mutagenesis in the E. coli fpg mutY strain. We dem-
onstrate that PC4 and its Saccharomyces cerevisiae ortholog
SUB1 are required for resistance to hydrogen peroxide and
function to prevent spontaneous and induced oxidative mu-
tagenesis. The oxidation resistance function of PC4 requires its
single-strand DNA (ssDNA) binding activity, which is not re-
quired for the transcription coactivator function of PC4 (56,
57). A function of PC4 in repair of oxidative DNA damage is
suggested by its physical and biochemical interactions with the
multifunctional human DNA repair protein XPG, the struc-
ture-specific endonuclease activity of which is essential for
nucleotide excision repair (NER) but which also plays impor-
tant nonenzymatic roles in base excision repair (BER) and
transcription-coupled repair (TCR) of oxidative damage (52a).
MATERIALS AND METHODS
Bacterial strains. The lacZ mutant E. coli strain cc104 and its isogenic deriv-
atives MV4705 (cc104 fpg::Tn10), MV4707 (cc104 mutY::Catr), and MV4709
(cc104 fpg::Tn10 mutY::Catr) were constructed by P1 transduction selecting
for the appropriate antibiotic resistance marker.
Bacterial mutagenesis assays. The papillation assay medium (39) contains
0.2% D-glucose, 1 A salts, 1 mM MgSO4, 5 g of thiamine hydrochloride/ml,
0.5 mM IPTG (isopropyl--D-thiogalactopyranoside), 40 g of X-Gal (5-bromo-
4-chloro-3-indolyl--D-galactopyranoside)/ml, 0.5 mg of phenyl--D-galactopyra-
noside (P-Gal)/ml, 50 g of carbenicillin/ml, and 2% agar. For pBAD24 induc-
tion, 0.2% L-arabinose (20) was added and the glucose concentration was
reduced to 0.05%. Papillation was scored 5 to 6 days after plating. Spontaneous
mutation frequencies (revertants/total cells) were quantitated by plating dilu-
tions of the overnight cultures of individual transformants on lactose and glucose
minimal media and incubating 3 days at 37°C. LacZ revertants were detected on
lactose plates, total colonies on glucose plates.
Construction of Fpg, hOGG1, and hMYH expression vectors. To overexpress
the E. coli Fpg protein, a 1-kbp EcoRI/HindIII fragment from V243 (39) was
subcloned into pTrc 99A (Pharmacia, Inc.) (pTrc-Fpg). To construct pTrc-
hOGG1, a 5.7-kbp XbaI/HindIII fragment from pET8c-OGG1-1a (42) (Y.
Nakabeppu, Kyushu University, Fukuoka, Japan) was subcloned into pTrc 99A.
To construct pTrc-hMYH, a 4.5-kbp StuI/BamHI fragment from pT7blue-
hMYH3-2 (43) (Y. Nakabeppu, Kyushu University) was subcloned into SmaI/
BamHI-linearized pTrc 99A.
* Corresponding author. Mailing address: Department of Molecular
Genetics and Microbiology, University of Massachusetts Medical
School, 55 Lake Ave. North, Worcester, MA 01655. Phone: (508) 856-
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Construction of wild-type and mutant PC4 expression vectors. Plasmids car-
rying the full-length coding sequences of the wild type (PC4-wt) or the ssDNA
binding-defective mutants (PC4-W89A and PC4-23) (57) were obtained from
M. Meisterernst (Munich, Germany). The full-length PC4 wild-type and mutant
protein coding sequences were isolated as NdeI and EcoRI fragments and
subcloned into the corresponding sites in pET-28b() to attach the six-histidine
tag to their amino termini. The insert containing NcoI and SalI fragments from
the pET-28() derivatives were subcloned into the corresponding sites of
pBAD24 for araBAD promoter-dependent expression. Expression of the six-
histidine-tagged PC4 proteins was verified by Western blotting using the anti-
Penta His antibody (QIAGEN).
Construction of yeast strains and expression vectors. The S. cerevisiae wild-
type strain FY833 (MATa his3200 leu21 lys2202 trp163 ura3-52) and the
sub1 mutant strain YMH476 (FY833 sub1::hisG) (59) were obtained from M.
Hampsey (Rutgers University). Additional sub1 mutants were constructed by
PCR-mediated one-step gene replacement methods (8). Cells were cultured
either in YPD (1% yeast extract, 2% peptone, 2% dextrose) or, for plasmid-
bearing strains, in synthetic complete medium lacking leucine or uracil (SC-leu
or SC-ura). To express PC4 in yeast strains, the coding sequence for amino acids
(aa) 40 to 127 was amplified by PCR using the PC4 cDNA clone initially isolated
from the genetic screen as the template with primers PC4-N (ACGCGTCGAC
ATGCAAAAGACAGGTGAGACTTCGAGAGCTCTG) and PC4-C (CCGCT
CGAGTCATCTTACAAATTCCTCTGC). The ATG initiation codon shown in
boldface along with the italicized sequences for SalI and XhoI restriction sites
were added for protein expression and cloning purposes. The SalI- and XhoI-t
reated PCR product was inserted into pMV611, which carries the LEU2 gene
from pRS315 (49) and the GPD promoter from p426-GPD (41). To express the
Sub1 protein, the SUB1 open reading frame was amplified from the FY833
genomic DNA by PCR using primers X001-SUB1f (GCTCTAGATGTCATATT
ACAACAGGTATAGG) and E292-SUB1r (GCGAATTCTTATTCTTCTTCAC
TTATGTCG). The italicized sequences for XbaI and EcoRI restriction sites
were introduced to the ends of the PCR product for cloning into p416-GPD,
which carries the URA3 gene for selection (41). MVY219 (rad2::TRP1) and
MVY221 (sub1 rad2::TRP1) RAD2 deletion strains were constructed by
transforming FY833 (wt) and YMH476 (sub1) with SalI-digested pWS521 (W.
Siede, University of North Texas Health Science Center).
H2O2 sensitivity and induced mutagenesis. Yeast strains were grown to mid-
log phase at 30°C, washed, and resuspended in phosphate-buffered saline. Cells
were then treated with H2O2 by shaking at 30°C for 1 h as indicated. Cells were
harvested by centrifugation, washed, resuspended in sterile deionized H2O, di-
luted, and plated on YPD for survival analysis of non-plasmid-bearing strains or
SC-leu or SC-ura for plasmid-bearing strains. Survival experiments were re-
peated from 3 to 10 times, and representative data indicating the reproducible
differences between strains are shown. To measure the can1r mutagenesis, cells
were plated on synthetic medium lacking arginine but containing 60 g of
canavanine/ml and incubated at 30°C for 3 to 4 days for survival and 4 to 5 days
for mutagenesis.
UV and MMS sensitivity tests. Yeast strains were grown to mid-log phase at
30°C, washed with water, suspended in phosphate-buffered saline, incubated with
the indicated concentrations of methyl methanesulfonate (MMS; Sigma Chem-
ical) for 1 h at 30°C, diluted, and plated on YPD plates. Surviving colonies were
counted after 3 to 4 days of incubation at 30°C. For UV dose response tests,
approximately 1,000 log-phase cells were placed in each spot on YPD plates.
Spots were irradiated with UV (  254 nm) in 30-J/m2 increments using a
Stratalinker UV Crosslinker (Stratagene). Plates were then incubated in the dark
at 30°C for 3 to 4 days.
Expression and purification of PC4 and XPG. Full-length wild-type PC4 was
expressed in the E. coli BL21(DE3) strain and purified according to the methods
of Ge et al. (18). The cDNA for human XPG (a generous gift from Stuart
Clarkson) was inserted into a pFASTBAC vector, expressed in High5 insect cells,
and purified to 95% homogeneity essentially as described previously (16). For
use only in the far-Western assays, a heart muscle kinase (HMK) recognition
sequence tag, RRASV, was added at the C terminus.
Protein-protein interaction assays. For far-Western analysis, human PC4 pro-
tein (1.5 g), human Nth1 protein (2.1 g), and E. coli EndoIII (3 g) were
separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (precast
4 to 20% gel; Bio-Rad), transferred to a polyvinylidene difluoride membrane,
and stained with Ponceau S to visualize the proteins on the membrane. The
membrane was then blocked with a blocking buffer (25 mM HEPES-KOH [pH
7.7], 25 mM NaCl, 5 mM MgCl2, 1 mM dithiothreitol [DTT], 1% nonfat milk,
0.1% NP-40) for 2 h at 4°C and probed overnight at 4°C on a rocker with blocking
buffer containing 150 mM KCl and 32P-labeled XPG with a HMK tag. The
membrane was washed with washing buffer (25 mM HEPES-KOH [pH 7.7], 25
mM NaCl, 150 mM KCl, 5 mM MgCl2, 1 mM DTT, 1% nonfat milk, 0.5%
NP-40), and interactions were visualized by both phosphorimager and auto-
radiography. For slot blot analysis, 1 g each of PC4, hNth1, and EndoIII was
applied to a nitrocellulose membrane, and the membrane was processed as
described above.
Electrophoretic mobility shift assay. The sequences of the oligonucleotides
used to form the bubble DNA substrate for the electrophoretic mobility shift
assay were as follows (with the central unpaired region of the substrates in bold):
10T-strand, 5	-GGGCAGACAACGTGGCGCTGTTTTTTTTTTGTGTCCTA
GCACAGCGTATG-3	; and 10C-strand, 5	-CATACGCTGTGCTAGGACACC
CCCCCCCCCCAGCGCCACGTTGTCTGCCC-3	.
The 10T-strand was 5	-end labeled with T4 polynucleotide kinase and
[
-32P]ATP and annealed with the complementary 10C-strand by heating for
3 min at 90°C and cooling to room temperature. The resulting DNA bubble
substrate was gel purified. Fifty femtomoles of 32P-labeled bubble DNA was
incubated at room temperature with XPG, PC4, or both for 20 min in a 20-l
reaction mixture containing 10 mM HEPES-KOH (pH 7.5), 110 mM KCl, 1 mM
EDTA, 1 mM DTT, 4% glycerol, and 0.2 g of poly(dI  C-dI  C). After the
incubation, the samples were loaded on a 4.5% nondenaturing polyacrylamide
gel (19:1, acrylamide to bisacrylamide). Electrophoresis was performed under
refrigeration at 150 V for 2 h in 0.5 Tris-borate-EDTA buffers. The gels were
analyzed by phosphorimager and ImageQuant software (Molecular Dynamics).
RESULTS
Suppression of the E. coli oxidative mutator phenotype. The
fpg mutY strain of E. coli was used to screen for human cDNAs
that express proteins that either prevent spontaneous DNA
oxidation or repair the DNA lesions produced. This E. coli
strain is a spontaneous mutator because Fpg repairs 8-oxoG,
the predominant oxidative DNA lesion, and MutY removes A
mispaired with 8-oxoG, a high-frequency mispairing event
during replication of template 8-oxoG lesions resulting in
GC3TA transversion mutations (37, 38, 40). Production of
ROS by normal metabolic processes leads to accumulation of
8-oxoG lesions in DNA and results in elevated spontaneous
mutagenesis (37). The GC3 TA transversions are detected
using the cc104 allele of lacZ, which reverts only by GC3 TA
transversion (14). On indicator medium, E. coli cells carrying
lacZ(cc104) produce distinctive white LacZ colonies contain-
ing dark blue LacZ revertant microcolonies, or papillae (Fig.
1) (37). Figure 1 compares the mutator phenotype of the fpg
mutY double mutant strain (Fig. 1B) with that of wild-type
E. coli (Fig. 1A) and shows the suppression of mutagenesis
resulting from the expression of E. coli and human DNA repair
genes. Complete suppression of the fpg mutY strain’s mutator
phenotype is seen upon high-level expression of the bacterial
fpg gene (Fig. 1C), reducing the frequency of transversions to
levels below that seen in the wild type (Fig. 1A). Since most of
the transversion mutations seen in the wild-type strain can also
be prevented by fpg overexpression (60), GC3TA transver-
sions can be considered a signature of oxidative DNA damage.
Suppression of the fpg mutY mutator phenotype is also seen
upon expression of the human 8-oxoG glycosylase, OGG1 (Fig.
1D), or the human MutY ortholog, MYH (Fig. 1E) (1, 3, 43,
46, 48, 50).
Isolation of the human PC4 gene. The PC4 gene was isolated
by transforming the E. coli fpg mutY strain with a human cDNA
library constructed in a bacterial expression vector (45, 54) and
then screening individual transformed colonies for suppres-
sion of the spontaneous mutator phenotype. PC4 is one of the
strong antimutators identified (Fig. 1F). Expression of PC4
provides complete mutation suppression under these condi-
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tions, as confirmed by a quantitative mutagenesis assay (Ta-
ble 1).
PC4 is a transcription cofactor mediating activator-depen-
dent transcription by RNA polymerase II (19, 32) through
interactions with sequence-specific activators and TFIIA of the
basal transcription machinery (19, 32). PC4 encodes a polypep-
tide of 127 aa (Fig. 2). Functional deletion analyses revealed a
bipartite structure of PC4 comprising an amino-terminal reg-
ulatory domain (aa 1 to 62) and a carboxyl-terminal, ssDNA
binding and dimerization domain (CTD; aa 63 to 127) (10, 28,
56, 57). The X-ray crystal structure of the PC4-CTD shows that
it forms a dimer with two ssDNA binding channels running in
opposite directions (10). Previously, in vitro transcription stud-
ies showed that a peptide comprised of aa 22 to 87 of PC4 is
necessary and sufficient for coactivation (28, 32, 56, 57) and
that the lysine-rich motif between aa 22 and 41 is required for
transcription activation (26, 28). It has also been demon-
strated that inactivation of the ssDNA binding activity does
not affect the ability of PC4 to function in transcription
activation (57).
The PC4 cDNA clone isolated in this study is truncated at its
5	 end, lacking the codons for the first 39 amino acid residues
but containing a short heterologous DNA sequence of un-
known origin encoding MPSNSAPAHGTSS fused to gluta-
mine 40 of PC4. The N-terminal truncation of PC4 removes
the lysine-rich motif required for coactivation (28) but leaves
intact the ssDNA binding and dimerization domains (10, 56).
This suggests that the ssDNA binding and dimerization motifs
alone are sufficient for PC4 to function as an oxidative anti-
mutator protein in E. coli. To examine this further and to rule
out effects of the heterologous upstream sequence, we ob-
tained the cloned full-length wild-type PC4 gene, transferred it
into the L-arabinose-inducible pBAD24 bacterial expression
vector (20), and tested its ability to function as an antimutator.
Figure 3A shows that wild-type PC4 is able to fully suppress the
mutator phenotype of the E. coli fpg mutY strain, indicating
that the full-length and truncated fusion forms of PC4 isolated
in this study are functionally similar.
ssDNA binding activity of PC4 is required for suppression
of oxidative mutagenesis. Since the PC4 clone we originally
isolated contained only the ssDNA binding and dimerization
domains of PC4, we tested if ssDNA binding activity is re-
quired for the antimutator activity in the fpg mutY strain of
E. coli by comparing the 23 and W89A ssDNA binding-
deficient mutants of PC4 constructed by Werten et al. (56) with
the full-length, wild-type PC4. In the absence of L-arabinose,
no protein expression was detectable by Western blotting (Fig.
3B, left panel) and no mutation suppression was detected (Fig.
3A, upper panels). In the presence of inducer, all forms of PC4
were expressed equally well (Fig. 3B). However, compared to
wild-type PC4, the ssDNA binding-deficient mutants were se-
FIG. 1. Mutator phenotype of E. coli fpg mutY and its suppression by bacterial and human DNA repair genes. Upper panels show the phenotype
of (A) wild-type E. coli cc104 carrying the GC3TA transversion-specific allele of lacZ and (B) its isogenic fpg mutY double mutant derivative. The
antimutator activity resulting from (C) expression of bacterial fpg protein (E. coli fpg mutY/pfpg), (D) expression of the human 8-oxoG DNA
glycosylase OGG1 (E. coli fpg mutY/phOGG1), (E) expression of the human MutY ortholog hMYH (E. coli fpg mutY/phMYH), and (F) expression
of the truncated form of PC4 isolated in this study (E. coli fpg mutY/pSE380-PC4).
TABLE 1. Mutation frequency of fpg mutY strains expressing
bacterial and human DNA repair genes
Strain Genotype Plasmid Mutation frequency(mutants/108 cells)a
MV4724 Wild type pTrc99A vector 3
MV4755 fpg mutY pTrc99A vector 2,750
MV4763 fpg mutY pTrc99A-fpg 0
MV4761 fpg mutY pTrc99A-hOGG1 11
MV4762 fpg mutY pTrc99A-hMYH 58
MV4722 fpg mutY pSE380b-PC4 0
a Representative data are shown.
b pSE380 is identical to pTrc99A except for the presence of additional cloning
sites in the vector.
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verely impaired in their ability to suppress the oxidative mu-
tator phenotype when expressed in the fpg mutY strain (Fig.
3A), thus demonstrating that the ssDNA binding activity is
required for the antimutator function of PC4 in the bacterial
assay and that the wild-type protein functions as well as the
truncated form of PC4 in this assay.
Yeast sub1 mutants are hypersensitive to hydrogen perox-
ide. To determine if PC4 functions to prevent oxidative mu-
FIG. 2. Structure of PC4 and its derivatives. The upper panel shows the domains of wild-type PC4. The protein region designated aa 22 to 87
is the minimal coactivator clone described by Kaiser et al. (28), and it is shown for comparison. The initial PC4 clone is the form of PC4 initially
isolated in our screen. The white amino-terminal box indicates the in-frame vector sequence fused to the 40 to 127 aa region of PC4. The PC4-CTD
expressed in yeast was constructed by adding an ATG codon 5	 to sequences encoding PC4 aa residues 40 through 127. The S. cerevisiae SUB1
gene is also shown, the boxes containing the dotted lines (not to scale) depict the heterologous 39-aa amino-terminal and 187-aa carboxyl-terminal
domains of unknown function.
FIG. 3. ssDNA binding activity of PC4 is required for mutation suppression in E. coli fpg mutY. Histidine-tagged forms of PC4 and its ssDNA
binding-defective mutants W89A and 23 are expressed from the L-arabinose-inducible araBAD promoter present on the pBAD24 vector. (A)
Upper panels show the mutator activity in the absence of L-arabinose, lower panels show the mutator activity of wild-type and mutant forms of
PC4 after induction by L-arabinose. (B) Left section shows the Western blotting using antihistidine antibody to determine levels of wild-type (WT)
and mutant protein expression; the right section shows the same gel stained with Coomassie brilliant blue.
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tagenesis in eukaryotes, we turned to yeast genetics. Sequence
analysis reveals that PC4 orthologs exist in all sequenced eu-
karyotic genomes and that the most conserved region is the
C-terminal ssDNA binding and dimerization domains. The S.
cerevisiae PC4 ortholog, termed Sub1 (31) or Tsp1 (22), shows
48% identity and 58% similarity when compared with the C-
terminal region (aa residues 63 to 127) of PC4 (2). Like its
human ortholog, Sub1 is involved in various aspects of tran-
scription but is not essential for viability (11, 22, 31, 59).
To determine if Sub1 plays a role in oxidation resistance, we
tested yeast sub1 mutants for phenotypes associated with
oxidative stress, DNA damage, or repair. Figure 4A shows that
the yeast sub1 mutant (59) obtained from M. Hampsey (Rut-
gers University) is extremely hypersensitive to hydrogen per-
oxide compared to its wild-type parent. To confirm this, we
disrupted the SUB1 gene in two other laboratory strains,
W303-1B (lab strain) and RDKY3023 (R. Kolodner, Univer-
sity of California, San Diego), and found similar degrees of
sensitization (data not shown). Reintroduction of the wild-type
SUB1 gene on the p416-GPD yeast expression vector (41) fully
restores peroxide resistance to the sub1 mutant, demonstrat-
ing that the observed peroxide sensitivity is solely due to the
sub1 mutation (Fig. 4A). In contrast, the sub1 mutant strain
does not cause increased sensitivity to methylation or UV
treatments (Fig. 5), suggesting that Sub1 does not play a role in
either NER or BER of alkylation damage but rather is specific
for protection from oxidative DNA damage.
Human PC4 can suppress the peroxide sensitivity of the
yeast sub1 mutant. To determine if the human PC4 gene can
function to protect against oxidative DNA damage, we tested if
FIG. 4. Peroxide sensitivity of the yeast sub1 mutant strain, its suppression by yeast SUB1, and truncated PC4 gene expression. (A) },
S. cerevisiae wild-type (wt) yeast carrying the vector p416-GPD; , S. cerevisiae sub1 mutant carrying the vector p416-GPD; Œ, wild type carrying
the full-length SUB1 gene; E, S. cerevisiae sub1 mutant carrying the full-length SUB1 gene expression plasmid. (B) }, S. cerevisiae wild-type yeast
carrying the vector pMV611; , S. cerevisiae sub1 mutant carrying the vector pMV611; Œ, wild type carrying the truncated PC4 gene expression
plasmid; E, S. cerevisiae sub1 mutant carrying the truncated PC4 gene expression plasmid.
FIG. 5. MMS and UV survival in the wild type (wt) and sub1 mutant of S. cerevisiae. (A) MMS survival of wild-type yeast (E) and the sub1
mutant (F). Data shown represent the averages of three experiments. Error bars indicate standard errors of the mean and are shown when they
extend beyond the symbol. (B) UV spot test. Overnight cultures, diluted to inoculate each spot with approximately 1,000 cells of the wild type
(upper row) and the sub1 mutant (lower row), were placed on YPD agar plates and exposed to increasing doses of UV.
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it suppresses the peroxide sensitivity of the yeast sub1 mutant
strain. We constructed a plasmid that expresses the truncated
form of PC4 by adding an ATG codon to the 5	 end of PC4
beginning with the glutamine 40 codon. This construct corre-
sponds to the PC4 coding sequence of the truncated form of
PC4 originally isolated (Fig. 2). Expression of this clone in
yeast results in a complete restoration of peroxide resistance
(Fig. 4B), indicating that the truncated form of PC4 can fully
substitute for the yeast SUB1 gene and strongly suggesting that
the human PC4 gene, like its yeast counterpart, functions in
oxidation resistance.
The yeast sub1 mutation increases spontaneous and in-
duced mutagenesis. Since many mutations affecting peroxide
sensitivity also affect spontaneous and peroxide-induced mu-
tagenesis, we tested if the sub1 mutation has such effects by
measuring the forward mutation frequency to canavanine re-
sistance. Canavanine resistance can result from a wide variety
of genetic changes including GC3TA transversions, and OGG1
mutants of yeast show a sevenfold increase in spontaneous
canavanine resistance mutagenesis (52). Figure 6 shows that
the sub1 mutant exhibits a twofold increase in both sponta-
neous and peroxide-induced mutagenesis, indicating that Sub1
protects against mutations arising from the low spontaneous
production of endogenous ROS and exposure to high levels of
exogenous hydrogen peroxide.
rad2 partially suppresses peroxide sensitivity of sub1. A
nonenzymatic function of XPG is essential for TCR of oxida-
tive damage (34) and has also been implicated in transcription
per se (9, 33). XPG also stimulates initiation of BER by the
NTH1 glycosylase that removes oxidized pyrimidines, again in
a nonenzymatic capacity (4, 30, 34). Furthermore, XPG also
interacts with and stimulates APE1, the major human AP en-
donuclease activity in BER, and appears to coordinate NTH1
and APE1 function in vitro (B. Haltiwanger and P. K. Cooper,
unpublished results). Because PC4 and Sub1 also have roles in
both transcription and resistance to oxidative damage, we won-
dered whether they might interact with XPG and its yeast
homolog Rad2, respectively. We therefore constructed a sub1
rad2 double mutant strain in order to see if these mutations
are epistatic or result in increased peroxide sensitivity. Inter-
estingly, the rad2mutation partially rescues the sub1mutant
strain, reducing its peroxide sensitivity (Fig. 7). This finding
suggests an interplay between Rad2 and Sub1 in minimizing
oxidative damage. In particular, it raises the possibility that in
the absence of Sub1, an activity of Rad2 responding to oxida-
tive damage is deleterious.
Direct interaction of PC4 with XPG. Since Sub1 evidently
functions in a pathway involving Rad2, we tested the possibility
of direct interaction between the human PC4 and XPG pro-
teins by far-Western analysis. To test PC4-XPG interaction,
32P-labeled XPG was used as a probe for PC4 transferred onto
a membrane from a sodium dodecyl sulfate-polyacrylamide gel
electrophoresis gel. A strong signal appears at the position
corresponding to PC4, indicating that XPG and PC4 directly
interact in the absence of DNA (Fig. 8A). Under these condi-
tions, XPG bound the positive-control human NTH1 but did
not bind its E. coli homolog EndoIII, the negative control. To
eliminate the possibility that the interaction might be due to
denaturation of PC4 during the electrophoresis step, we also
tested native PC4 bound directly to a membrane in a slot blot
assay (Fig. 8B). Notably, the interaction of PC4 and XPG is
preserved, providing additional evidence for its specificity.
PC4 binding to bubble substrates is enhanced by XPG. The
preferred DNA substrates for binding by PC4 are DNA bubble
structures (56). Perhaps not coincidentally, XPG also binds
stably, specifically, and with high affinity to DNA bubbles re-
sembling in size the open regions associated with transcription
(A. H. Sarker, S. E. Tsutakawa, and P. K. Cooper, unpublished
results). In order to determine if these two proteins compete
for this substrate or interact synergistically, we tested if the
presence of XPG affects binding by full-length PC4 protein to
a DNA bubble substrate having a central 10-bp unpaired re-
gion. XPG alone bound to this substrate to form a slowly
migrating complex (Fig. 9A, lane 2). In the absence of XPG,
PC4 also bound specifically to the 10-bp DNA bubble (Fig. 9A,
lanes 9 to 13), with complete binding at 352 nM (lane 12). We
also observed an additional shifted band that appears only at
FIG. 6. The yeast sub1 mutation results in elevated mutagenesis.
Spontaneous and induced mutagenesis in the wild type (wt) and the
sub1 mutant of S. cerevisiae. The insert expands the view of the
mutagenesis in the absence of exogenous peroxide addition.
FIG. 7. Partial suppression of sub1 hydrogen peroxide sensitivity by
rad2. E, wild type (wt); Œ, sub1 mutant strain; , rad2 mutant strain;
}, sub1 rad2 double mutant strain. Representative data are shown.
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the highest concentration assayed, 704 nM (Fig. 9A, lane 13).
Since it is known that PC4 binds as a dimer (10, 56), we
postulate that the slower-migrating shifted species represents a
double complex of PC4 dimers bound to DNA, as has been
previously observed by others (56, 57). To determine if XPG
affects PC4 interaction with DNA bubbles, we preincubated
the 10-bp bubble DNA with XPG and then added PC4 at
various concentrations (Fig. 9A, lanes 3 to 7). XPG strongly
stimulated PC4 binding, with complete binding achieved at the
lowest PC4 protein concentration analyzed (44 nM, lane 3),
compared to 352 nM in the absence of XPG. Quantitation
from the phosphorimage in Fig. 9A of the amount of substrate
shifted as a function of PC4 concentration reveals dramatically
increased binding of PC4 in the presence of XPG (Fig. 9B).
Correspondingly, the PC4 tetramer-bound complex appears at
lower concentrations (352 nM, lane 6) in the presence of XPG.
Interestingly, in no case did we observe a trimeric complex of
XPG, PC4, and DNA. At approximately equimolar ratios of
PC4 and XPG (44 nM, lane 3), there appears to be a complete
replacement of XPG by PC4 in the protein-bound DNA com-
plexes. This observation is significant, since XPG itself remains
stably bound to bubble DNA substrate even in the presence of
high concentrations of competitor or other DNA binding pro-
teins with which XPG interacts (A. H. Sarker, S. E. Tsutakawa,
and P. K. Cooper, unpublished data). To test if PC4-mediated
displacement of XPG is dependent upon the order of addition,
the proteins were added either in order or simultaneously. In
all cases, only the complexes migrating to the positions de-
tected when PC4 alone is added are seen (Fig. 9C, lanes 3 to 5).
These results strongly suggest that XPG recruits PC4 to bub-
ble-containing DNA substrates and that binding of PC4 dis-
places XPG from the bubble substrate.
DISCUSSION
In this study we identified PC4 as a human protein capable
of suppressing the oxidative mutator phenotype of the fpg
mutY strain of E. coli. We characterized the PC4 gene and its
yeast ortholog, demonstrating that a yeast mutant devoid of its
PC4 ortholog, SUB1, is sensitive to hydrogen peroxide, exhibits
a spontaneous mutator phenotype, and is hypermutable upon
treatment with hydrogen peroxide. These results indicate that
Sub1 is a eukaryotic peroxide resistance protein. The result
demonstrating that expression of the human gene can restore
peroxide resistance to the sub1 mutant of yeast suggests a
similar function for the human PC4 protein. These observa-
tions, combined with previous results (54), demonstrate the
utility of the bacterial screen for the identification of unique
human oxidation resistance proteins.
The previously identified transcriptional coactivator func-
tion of PC4 does not require the ssDNA binding activity (56,
57) contained in the most highly conserved region of this fam-
ily of proteins. A novel function in DNA repair for the ssDNA
binding activity of PC4 is indicated by the result that the trun-
cated form of human PC4, lacking sequences required for
transcription coactivation, can function to suppress oxidative
mutagenesis in bacteria and can complement the peroxide
sensitivity of a yeast sub1 mutant. This conclusion is further
supported by the observation that the DNA binding-defective
mutant forms of human PC4 are incapable of functioning as
antimutators in the bacterial oxidative mutagenesis assays.
Thus, we propose that PC4 functions both in transcription and
in repair of oxidative DNA damage. These two functions are
genetically separable; mutations in PC4’s amino terminal do-
main primarily affect transcription coactivation, and mutations
in its ssDNA binding domain primarily affect DNA repair.
Taken together, the observations that Sub1 functions in a
repair pathway involving Rad2 and that PC4 directly and func-
tionally interacts with the DNA repair protein XPG suggest a
role for PC4 in the repair of oxidative damage. XPG functions
in multiple DNA repair pathways in human cells. Both its
enzymatic activity as a structure-specific endonuclease and a
nonenzymatic function evidently involve interactions with
other proteins required in NER (16, 55). In addition, a non-
enzymatic function of XPG is required for TCR of oxidative
DNA damage, evidently at an early step presumably involving
recognition of RNA polymerase stalled at a lesion (34). XPG
FIG. 8. Interaction of PC4 and XPG. Slot blot and far-Western tests were performed as described in Materials and Methods. Full-length
hNTH1 and E. coli EndoIII were used as the positive and negative controls, respectively. The left portions of the panels show Ponceau S-stained
images of the membrane, and right portions show the results of incubation of membranes with 32P-labeled XPG-HMK. The position of the protein
in the membrane is indicated.
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also both stimulates BER enzymes in vitro through direct in-
teractions (4, 30; B. M. Haltiwanger and P. K. Cooper, unpub-
lished data) and stimulates removal of oxidative lesions in the
cell (34). A role for PC4 in NER is unlikely, because we have
shown that deletion of its yeast homolog does not affect sen-
sitivity to UV. Thus, the interaction of PC4 with XPG in repair
of oxidative damage could conceivably affect either global
BER or TCR. The stable, specific binding of XPG to double-
strand DNA containing unpaired regions is functionally sepa-
rate from its structure-specific endonuclease activity (25; Sarker,
Tsutakawa, and Cooper, unpublished), and an attractive pos-
sibility is that its preferential binding to the transcription-sized
bubble is relevant to the TCR function of XPG. In TCR, rapid
preferential repair is initiated on transcribed strands after an
RNA polymerase is stalled at a DNA lesion, and it is thought
that the RNA polymerase must be removed or remodeled in
order for the repair enzymes to gain access to the lesion (for a
review, see reference 51). XPG is apparently required along
with CSB and TFIIH for this early step in TCR (34; S. E.
Tsutakawa and P. K. Cooper, unpublished). Our finding that
XPG bound to a DNA bubble substrate recruits PC4 to the
complex with a resulting displacement of XPG suggests the
possibility that PC4 may be involved in TCR at a step imme-
diately following XPG.
The observed reduction of peroxide sensitivity seen when
the sub1 rad2 double mutant is compared with the sub1
single mutant strain is consistent with the idea that Rad2 pro-
duces a potentially lethal intermediate in repair of oxidative dam-
age that requires Sub1 for efficient further processing. Inability to
release Rad2 from the partially repaired lesion (or lesion plus
stalled RNA polymerase) may block access to proteins required
to complete subsequent steps of repair. According to this model,
the accumulation of unrepaired or inefficiently repaired interme-
diates leads to increased lethality in the sub1 mutant. Blocking
production of the intermediates by eliminating Rad2 improves
survival because the initial damage is not as lethal as the DNA
repair intermediate. It should be noted that the effect of the rad2
mutation is only partial, suggesting that Sub1 may either have
additional functions in DNA repair or may perform similar func-
tions for other DNA repair enzymes.
FIG. 9. (A) XPG protein enhances PC4 binding to DNA bubble substrates. Portions (2.5 nM) of the 10-nucleotide (nt) bubble DNA substrate
were incubated with 41 nM purified XPG (lanes 2 to 7) or without XPG (lanes 9 to 13) as described in Materials and Methods. Reaction mixtures
were supplemented with 44 (lanes 3 and 9), 88 (lanes 4 and 10), 176 (lanes 5 and 11), 352 (lanes 6 and 12), and 704 nM (lanes 7 and 13) human
PC4 protein. Samples were loaded onto a 4.5% native gel, and electrophoresis was conducted at 150 V for 2 h at 4°C. The gel was dried and exposed
on a phosphorimager screen. No protein was added in lanes 1 and 8. (B) Quantitative representation of the effect of XPG on PC4 binding. (C)
Displacement of XPG by PC4 does not depend on the order of addition of the proteins. In all experiments, 44 nM XPG and 352 nM PC4 protein
and the same DNA bubble substrates shown in Fig. 8 were used. Lanes 2 and 3, XPG was first incubated with the DNA bubble substrate (lane
2) and PC4 protein was then added (lane 3); lane 4, PC4 protein was first incubated with the DNA bubble substrate followed by XPG addition;
lane 5, XPG and PC4 were mixed first and then added to the DNA bubble substrate; lane 6, PC4 alone was incubated with the substrate. Samples
were run in a 4.5% native gel, and electrophoresis was conducted at 150 V for 2 h in the cold. The gel was dried and exposed on a phosphorimager screen.
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In the context of this model, our finding that PC4 displaces
XPG that is stably bound to a DNA bubble structure suggests
the possibility that PC4 is required in TCR for release of XPG
to allow subsequent processing either of the lesion itself or of
the stalled RNA polymerase. Significantly, a requirement for
an XPG release factor in NER has recently been suggested by
the results of Riedl et al., who found that XPG was not re-
leased from the DNA substrate after excision of the lesion in
vitro without the addition of an unknown factor present in
nuclear extracts (47). While this NER release factor is presum-
ably not PC4, since deletion of SUB1 does not result in sensi-
tivity to UV, it is possible that XPG similarly is not released on
its own after its function in TCR but requires PC4 in order to
turn over. The observation that PC4 stimulates XPG release is
particularly intriguing in light of results demonstrating that
PC4 can stimulate DNA synthesis via an interaction with rep-
lication protein A (44). A possible explanation combining all
these results is that PC4 may function in TCR as an interme-
diary between RNA polymerase removal or remodeling by
XPG together with other TCR proteins, possibly clearing the
initial TCR machinery from the damaged region, and subse-
quent steps including recruitment of repair enzymes and syn-
thesis of the repair patch. The observation that PC4 blocks
RNA polymerase elongation in vitro and the ability of TFIIH
to alleviate this block (17, 57) raise the possibility that PC4 may
also have additional functions in TCR that affect the resump-
tion of transcription. Clearly, the close association of PC4 with
other transcriptional processes and components of the tran-
scription machinery makes a possible role for PC4 in transcrip-
tion-coupled DNA repair processes particularly interesting.
However, it is presently unclear if PC4 functions in XPG-
stimulated BER, XPG-dependent TCR of oxidative DNA
damage, or both, and further experimentation will be required
to elucidate its possible roles in these processes. In this con-
nection, it should be noted that the lack of sensitivity of the
sub1 mutant to UV does not rule out a requirement for PC4
in TC-NER (TCR of UV damage), since loss of TCR by
deletion of RAD26 (the yeast homolog of CSB) does not
render yeast sensitive to UV (53). Thus, the postulated role for
PC4 in TCR as a release factor for XPG could conceivably
apply to TCR of UV and oxidative lesions.
The function of PC4 in XPG-related DNA repair processes
does not readily explain the ability of this protein to function in
the E. coli oxidative antimutator assay. However, since the
highly sensitive E. coli antimutator assay requires only a small
number of repair events per cell per generation to reveal sup-
pression of spontaneous mutagenesis, the repair-enhancing ac-
tivity of PC4 need not be very efficient. The activity we ob-
served could be due to a general effect of PC4 binding to
damaged DNA or to unpaired DNA regions produced as in-
termediates of repair, creating a more accessible environment
for additional E. coli DNA repair factors. It is unlikely that
protein-protein interactions between human PC4 protein and
bacterial DNA repair proteins would be functional, and more-
over, E. coli does not encode any proteins homologous to PC4.
While the interaction of PC4 with XPG implicates it in an
XPG-dependent DNA repair pathway in human cells, it may
also function in a more general fashion to stimulate, stabilize,
or assist DNA repair by other factors via a direct interaction
with DNA, as it evidently can do in E. coli. Expression of
human PC4 in either the wild type or the fpg mutY double
mutant strain of E. coli does not result in enhanced resistance
to the lethal effects of hydrogen peroxide exposure (data not
shown). However, since fpg and mutY mutations have little or
no effect on peroxide lethality (unpublished observations), it is
unclear if this observation indicates a specificity of PC4 for
repair of nonlethal lesions, such as 8-oxoG, or that the DNA
repair activity required for mutation suppression when PC4 is
expressed in bacteria is weak.
Sub1 mutations in yeast result in increased spontaneous and
induced oxidative mutagenesis and lethality. Since expression
of the PC4 protein in yeast can restore the wild-type pheno-
type, it suggests that the human PC4 protein may also function to
prevent mutations resulting from oxidative DNA damage in hu-
man cells. Mutations that cause increased spontaneous and dam-
age-induced mutagenesis cause an increased risk of cancer (24).
PC4 maps to chromosome 15p13, a region that frequently suffers
from loss of heterozygosity in bladder and lung tumors (5, 58).
This has been interpreted to suggest that the regulatory proper-
ties of PC4 may be important in tumor suppression, and support
for this hypothesis has been presented previously (29). However,
our findings suggest an alternative, or additional, mechanism for
PC4 in tumor suppression. Loss of PC4 function may also in-
crease the rate of mutagenesis resulting from spontaneous or
induced oxidative DNA damage in humans. This can increase the
level of mutations leading to transformation or secondary muta-
tions within tumors leading to tumor promotion.
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